Herpes zoster: A Review of Clinical Manifestations and Management

• Published in: Viruses Vol. 14; no. 2; p. 192
• Main Authors: Patil, Anant, Goldust, Mohamad, Wollina, Uwe
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 19.01.2022; MDPI
• Subjects: Acyclovir; Anemia; Chicken pox; chickenpox; Chronic pain; complications; Coronaviruses; COVID-19; COVID-19 infection; COVID-19 vaccines; Disease Management; disease prevention; Disease transmission; distress; Epidemiology; Fetuses; gastrointestinal system; Glycoprotein E; glycoproteins; Heparan sulfate; Herpes viruses; Herpes zoster; Herpes Zoster - complications; Herpes Zoster - drug therapy; Herpes Zoster - physiopathology; Herpes Zoster - prevention & control; Herpesvirus 3, Human - pathogenicity; Herpesvirus Vaccines - administration & dosage; Herpesvirus Vaccines - classification; Herpesvirus Vaccines - immunology; Human alphaherpesvirus 3; Humans; Immunocompromised Host; Immunocompromised hosts; Immunosuppression; Incidence; Infections; Inflammation; Kinases; Latent Infection - virology; live vaccines; Morbidity; Mortality; Nervous system; Neuralgia; Neuralgia, Postherpetic - virology; Pain; Pandemics; Patients; prevention; Prophylaxis; Review; Risk Factors; subunit vaccines; treatment; Vaccination; Vaccines; Vaccines, Synthetic - administration & dosage; Varicella; Varicella-zoster virus; Vasculitis; Viruses; epidemiology; treatment; Herpes zoster; Varicella-zoster virus; complications; prevention

The Varicella-zoster virus (VZV) or human herpes virus 3 is a neurotropic human alpha herpes virus responsible for chickenpox/varicella and shingles/Herpes zoster (HZ). This review will focus on HZ. Since HZ is secondary to varicella, its incidence increases with age. In children and youngsters, HZ...